• Create the Future to Overcome Cancer

 


Notice from Noile

Notice From Noile about Impersonation Message (PDF)

News

2026/06/02
Joint Research Project on in vivo CAR-T Therapy Conducted by The University of Tokyo and Yamaguchi University, Collaborative Partners of Noile-Immune, Awarded AMED FY2026 “Project for Promotion of Cancer Research and Therapeutic Evolution”
2026/06/01
AMED FY2026 “Translational Research Project” Grant Awarded to a Joint Research and Development Project Conducted by Yamaguchi University and Kyushu University, Collaborative Partners of Noile-Immune
2026/05/20
Seminar Presentation at INTERPHEX WEEK TOKYO 2026 / Regenerative Medicine Expo Tokyo 2026

Noile-Immune is pleased to announce that our President & CEO, Koji Tamada, MD, Ph.D. (Professor, Department of Immunology, Yamaguchi University Graduate School of Medicine/ Director, Research Institute for Cell Design Medical Science, Yamaguchi University), delivered a presentation on the latest trends in next-generation CAR-T therapies and their prospects for social implementation at a seminar held during INTERPHEX WEEK TOKYO 2026 / Regenerative Medicine Expo Tokyo 2026 (from Wednesday, May 20 to Friday, May 22, 2026 at Makuhari Messe in Chiba City).


2026/05/18
Notice of Ending Collaboration Agreement with Adaptimmune Limited
2026/05/13
Our Position Regarding the Matter Disclosed by Takara Bio Inc.
Details